Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Preventive Care
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Osteoarthritis (OA) is the most common form of arthritis. It is a joint disease caused by the breakdown of cartilage -- the firm, rubbery tissue that cushions bones at joints.
Healthy cartilage allows bones to glide over one another, and cartilage absorbs energy from the shock of physical movement.
- 0 Comments
Jan 15, 2009 -
Another year, another resolution. It's hard to eat healthy when your refrigerator is stocked with temptation. And it's hard to get off on the right foot with any resolution when your home base is a mess.
- 9 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the FDA approved LIALDA, the first once-daily mesalamine pill for treating mild-to-moderate ulcerative colitis. Other types of mesalamine need to be taken several times a day.
Genetic Research
Scientists have made an important discovery by identifying a gene associated with inflammatory bowel disease.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Biologic Drugs
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Complications
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Research:
- Patients who have the most common type of gastric bypass surgery, the Roux-en-Y, are at increased risk for kidney stones, beginning 6 months after surgery, according to a study published in 2006.
Causes of Kidney Stones:
- Calcium stones form when there is an imbalance in the urine substances that promote and block the formation of stones. Often, the cause of this imbalance is unknown.
- Having acidic urine or too much uric acid in the body leads to the formation of uric acid stones.
- Struvite stones are almost always caused by urinary tract infections due to bacteria that produce certain enzymes.
- Other stones, including cystine and xanthine stones, are usually due to genetic abnormalities.
Treatments:
- In about 85% of patients, the kidney stones are small enough that they pass through normal urination, usually within 2 - 3 days.
- Certain medications can prevent recurrence of stones in people who are at high risk.
- Extracorporeal shock wave lithotripsy (ESWL) is a technique that uses sound waves (ultrasound) to break up simple stones in the kidney or upper urinary tract. The shock waves are delivered from outside the body.
- Surgery may be necessary if the stone or stones are too big to pass, and cannot be broken down through ESWL.
- A change of diet and increased drinking of fluids, especially water, will help prevent a recurrence.
Introduction
Kidney stones are hard, solid rocks that form in the urinary tract.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Reproductive System
- Risk Factors
- Causes
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Assisted Reproductive Techn...
- Complications of Assisted R...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New At-Home Fertility Test for Couples
Fertell is a new at-home fertility test kit for couples. It screens for sperm motility concentrations and follicle-stimulating hormone (FSH) levels. Fertell may be helpful as an initial test for infertility, but for a definitive diagnosis it is important to consult a doctor.
- 0 Comments
Aug 15, 2007 -
My refrigerator has a bunch of magnets to motivate my through my days -- The magnets from the gorgeous places we've traveled make me smile and my "To Do" magnet keeps my life in check. We've seen healthy food magnets but why not stick some fitness magnets on there to motivate you to get moving.
This cute little set of yoga magnets ($8.95) includes five yoga pose magnets with written instructions.
- 6 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Urinary Tract Infections (UTIs) in the United States
According to Urologic Diseases in America, a report published in 2007 by the U.S. National Institutes of Health:
- UTIs are the most expensive of all urologic diseases, accounting for about $3.5 billion a year in medical costs, including $96.4 million in prescriptions.
- Over 60% of women will experience a UTI at least once in their lifetime. At least a third of women experience a UTI by the time they are 24 years old.
- Only 20% of UTIs occur in men.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Surgery and Devices
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Permanent Implantable Heart Approved
In 2006, the FDA approved the first permanent artificial heart. The AbiCor is intended for patients who are not eligible for heart transplants and who are only expected to survive about a month without medical treatment. Patients who received the AbiCor have survived, on average, about 5 months.
- 0 Comments